ArticleACS omega2026
Exploiting a Microdisk Array Device for Enhanced Microextraction of Indomethacin from Human Urine.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel microdisk array (MDA)-based microextraction approach was developed and applied for the determination of indomethacin in human urine prior to HPLC-UV analysis. The MDA represents an innovative, reusable extraction format that combines miniaturization with an array-based architecture to enhance mass transfer while minimizing sample handling and solvent consumption. The device was constructed by concentrically mounting two C18 microdisks onto a stainless-steel spinal needle secured with frit-based stoppers. Extraction was carried out by immersing the MDA device in 1500 μL of the aqueous sample for 20 min, followed by a brief water-rinsing step and desorption of the analytes in 1000 μL of a 50/50 (v/v) water/acetonitrile mixture. Key parameters affecting the adsorption and elution efficiency were systematically optimized. Under optimal conditions, the method showed linearity in the range of 50-1000 ng/mL, with a limit of detection of 14 ng/mL. The intra- and interday precision values were below 16.7%, and accuracy, expressed as relative recoveries, ranged from 91.4% to 108.7%. The environmental sustainability of the proposed method was assessed using the MA index, confirming its reduced environmental footprint. The practical applicability of MDA-based microextraction was demonstrated through the successful analysis of urine samples collected after oral administration of indomethacin-containing pharmaceutical products.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.